Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5222)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 28, 2022 (publication date) through Jun 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ray G. Management of liver diseases: Current perspectives. World J Gastroenterol 2022; 28(40): 5818-5826 [PMID: 36353204 DOI: 10.3748/wjg.v28.i40.5818] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i40/5818.htm |
| Number | Citing Articles |
| 1 |
Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, Sakurako Ito, Kentaro Mishima, Akihiko Kondo, Keiko Mizuno, Hiroki Takami, Takayuki Komatsu, Tomohisa Nomura, Manabu Sugita. Current perspectives of viral hepatitis. World Journal of Gastroenterology 2024; 30(18): 2402-2417 doi: 10.3748/wjg.v30.i18.2402
|
| 2 |
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva. Old age as a risk factor for liver diseases: Modern therapeutic approaches. Experimental Gerontology 2023; 184: 112334 doi: 10.1016/j.exger.2023.112334
|
| 3 |
Feifei Lu, Yao Meng, Xiaoting Song, Xiaotong Li, Zhuang Liu, Chunru Gu, Xiaojie Zheng, Yi Jing, Wei Cai, Kanokwan Pinyopornpanish, Andrea Mancuso, Fernando Gomes Romeiro, Nahum Méndez-Sánchez, Xingshun Qi. Artificial Intelligence in Liver Diseases: Recent Advances. Advances in Therapy 2024; 41(3): 967 doi: 10.1007/s12325-024-02781-5
|
| 4 |
Li-jiao Sun, Xin Chen, Sai Zhu, Jin-jin Xu, Xiao-feng Li, Shao-xi Diao, Ying-li Yang, Jin-yu Liu, Jia-nan Wang, Ying-yin Sun, Cheng Huang, Xiao-ming Meng, Hua Wang, Xiong-wen Lv, Jun Li. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2. Acta Pharmacologica Sinica 2024; 45(2): 354 doi: 10.1038/s41401-023-01171-x
|
| 5 |
F. V. Hladkykh, I. V. Bielochkina, I. V. Koshurba, M. O. Chyzh. Modern hepatoprotection: a narrative review of existing approaches and prospects for the use of biotechnological drugs. Modern medical technology 2023; (3): 58 doi: 10.34287/MMT.3(58).2023.9
|
| 6 |
Valentin Blank, Thomas Karlas, Ulf Anderegg, Johannes Wiegand, Josi Arnold, Linnaeus Bundalian, Gabriela‐Diana Le Duc, Christiane Körner, Thomas Ebert, Anja Saalbach. Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease. Liver International 2024; doi: 10.1111/liv.15956
|
| 7 |
Darya Pon`kina, Sergey Kuranov, Mikhail Khvostov, Nataliya Zhukova, Yulia Meshkova, Mariya Marenina, Olga Luzina, Tatyana Tolstikova, Nariman Salakhutdinov. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules 2023; 28(1): 396 doi: 10.3390/molecules28010396
|
| 8 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
| 9 |
Jie Huang, Ding-Wei Xu, Ao Li. Can laparoscopic splenectomy and azygoportal disconnection be safely performed in patients presenting with cirrhosis, hypersplenism and gastroesophageal variceal bleeding? How to do it, tips and tricks (with videos). Current Problems in Surgery 2024; : 101501 doi: 10.1016/j.cpsurg.2024.101501
|